25 "

: Sutent 25 Mg. ?  »
|
-

PER OS

Capsules

Sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. Sutent is indicated for the treatment of advanced renal cell carcinoma.Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.

136 90 31431 00

Pfizer Italia S.r.l., Italy

06/2012 - 06/2022

.
, .
.
/
Sunitinib as malate 25 MG
Blister pvc/aclar/aluminium 7 x CAPSULES 24
Blister pvc/aclar/aluminium 14 x CAPSULES 24
Blister pvc/aclar/aluminium 21 x CAPSULES 24
Blister pvc/aclar/aluminium 28 x CAPSULES 24
Blister pvc/aclar/aluminium 56 x CAPSULES 24
Bottle hdpe 28 x CAPSULES 24
Bottle hdpe 30 x CAPSULES 24

*

*

 

.

 
" !
 
301
-